Clinical Trial Update: Effect of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety and feasibility of administering human amniotic epithelial cells to children with spastic cerebral palsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Human Amniotic Epithelial Cells (human amniotic epithelial cells)

Snippet

Sponsor: The Second Affiliated Hospital of Fujian Medical University | Conditions: Spastic Cerebral Palsy | Phase 1 | Status: UNKNOWN